Dynavax Announces Second Quarter 2019 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/13/2026
- Nasdaq falls ahead of earnings, economic data while oil rallies
- Oil prices rise on Saudi Arabia attacks, overshadowing Trump's diesel deal
- Will surging equity supply derail the U.S. bull market? Goldman Sachs weighs in
- Broadcom CEO says many AI investors are gamblers
- "Not buying Chipotle": Starbucks squashes blockbuster acquisition speculation
- Bausch + Lomb names Appio interim CEO as Saunders departs
- Cerebras Systems hits new 52-week low on unlock concerns
- Getty Images to go private via prepackaged Chapter 11 restructuring
- Kroger (KR) To Cut Corporate Workforce By About 3,000 Over 3 Years - Bloomberg
- Sysco calls on Teamsters to end LA strike after economic deal reached
Dynavax (DVAX) Misses Q2 EPS by 10c
August 7, 2019 5:20 PM EDTDynavax (NASDAQ: DVAX) reported Q2 EPS of ($0.66), $0.10 worse than the analyst estimate of ($0.56). Revenue for the quarter came in at $8.3 million versus the consensus estimate of $9.14 million.
HEPLISAV-B net product revenue was $8.3 million for the second quarter of this year, which was in line... More



